INTERVIEW: Acquired assets key to Shire's 'entrepreneurial' approach to regen medicine
This article was originally published in Scrip
Executive Summary
The evolution of Shire's entrepreneurial regenerative medicine business continues with the appointment of Jeff Jonas as president of the division, which has been headquartered in San Diego, US since the $750 million acquisition of Advanced BioHealing and its bio-engineered skin substitute for diabetic foot ulcers Dermagraft in 2011 (scripintelligence.com, 18 May 2011).